A clinical review of early outcomes from contemporary flow modulation versus open, fenestrated and branch technologies in the management of thoracoabdominal aortic aneurysm.

摘要: Traditional therapeutic options for complex thoracoabdominal aneurysm include open repair, hybrid repair or endovascular (involving fenestrated branched endografts). The Streamliner Multilayer Flow Modulator has been available treatment of aneurysms since 2010. Its design permits blood flow to perfuse through the mesh in a modus that preserves collateral branch patency, while modulating turbulent laminar within device. then stagnates over time surrounding sac. Significant complications, including paraplegia, renal failure and cerebrovascular accident, are much lower with treatment. Application aortic pathologies presents novel solution an, as yet, unmet clinical need, resulted promising outcomes when compared existing solutions. offers potential patients is not just confined those complexity dictates no other management options. While current literature illustrates there decreased risk mortality associated complications this new disruptive technology utilised, still need prospective, long-term trials, well comparative trials accurately assess both precise reproducible. This article review regarding contemporary open, managements, presenting early outcomes.